Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuppan, D
Right arrow Articles by Freitag, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuppan, D
Right arrow Articles by Freitag, T
Topic Collections
Right arrowRelated Article
Gut 2004;53:622-624
© 2004 by BMJ Publishing Group Ltd & British Society of Gastroenterology


COMMENTARY

Crohn's disease

Fistulising Crohn’s disease: MMPs gone awry

D Schuppan, T Freitag

Department of Medicine I, University of Erlangen-Nürnberg, Germany

Correspondence to:
Correspondence to:
Professor D Schuppan
Department of Medicine I, University of Erlangen-Nürnberg, Ulmenweg 18, 91054 Erlangen, Germany; detlef.schuppan@med1.imed.uni-erlangen.de


Broadening our understanding of the role of matrix metalloproteinases in Crohn’s disease

Keywords: fibrosis; inflammatory bowel disease; proteolysis; matrix metalloproteinases; tissue inhibitor of metalloproteinase; ulcerative colitis; vitronectin receptor; Crohn’s disease; fistulae

The first 150 words of the full text of this article appear below.

Fistulae are a common complication of Crohn’s disease (CD), and their most common perianal manifestation is present in 14–38% of CD patients in referral populations.1 Despite advances in conservative treatment, fistulae rarely heal, while surgical resection is effective but frequently does not prevent local recurrence or fistulising disease at other sites.1 Remodelling of the extracellular matrix (ECM) is a key event in chronic bowel inflammation,2,3 especially in CD which is characterised by both active fibrogenesis (that is, ECM production and deposition), leading, for example, to stricture formation, and by enhanced fibrolyis (that is, breakdown and removal of ECM), such as occurs in fistula formation. While fibroblasts and myofibroblasts, and to a minor degree endothelial and epithelial cells, produce the intestinal ECM, many more cell types are involved in ECM breakdown by releasing a broad spectrum of enzymes that can degrade essentially every ECM component, such as the various . . . [Full text of this article]


Related Article

Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn’s disease
T Kirkegaard, A Hansen, E Bruun, and J Brynskov
Gut 2004 53: 701-709. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
PhysiologyHome page
N. Sengupta and T. T. MacDonald
The Role of Matrix Metalloproteinases in Stromal/Epithelial Interactions in the Gut
Physiology, December 1, 2007; 22(6): 401 - 409.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Society of Gastroenterology